Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Chabre

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Journal De Radiologie|September 6, 2005
[Imaging of adrenal ganglioneuroma: a case report]C Dubois, A Jankowski, C Gay-Jeune, et al.
Annales De Cardiologie Et D'Angeiologie|May 17, 2017
[Hyponatremic-hypertensive syndrome successfully treated by endovascular therapy: A case report]G Rigault, B Franko, O Chabre, et al.
Neuro-Chirurgie|June 12, 2002
[Role of perioperative biological tests during the performance and follow-up of corticotroph adenoma exeresis]J G Passagia, E Gay, O Chabre, et al.
The Journal of Biological Chemistry|January 5, 1992
Recombinant Gq alpha. Mutational activation and coupling to receptors and phospholipase CB R Conklin, O Chabre, Y H Wong, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 4, 2007
[Diagnosis and post-operative evolution of patients operated for adrenal adenoma (Conn syndrome). A 12-years retrospective study]C Vesin, O Chabre, J M Mallion, et al.
Annales De Chirurgie|March 31, 2004
[Pelvic muscular metastasis of well differentiated thyroid carcinoma]P C J Chaffanjon, N Sturm, J-P Caravel, et al.
Diabetes & Metabolism|December 3, 2014
Malignant insulinoma may arise during the course of type 1 diabetes mellitus: A case reportS Lablanche, M Chobert-Bakouline, O Risse, et al.
Presse Medicale (Paris, France : 1983)|February 22, 1992
[Cutaneous lesion associated with multiple endocrine neoplasms type 2A (Sipple's syndrome). An early clinical marker]O Chabre, F Labat-Moleur, F Berthod, et al.
Endocrine-Related Cancer|June 13, 2013
Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patientsO Chabre, R Libé, G Assie, et al.
Clinical Nuclear Medicine|June 11, 1999
In-111 pentetreotide scintigraphy to monitor nonsecreting neuroendocrine tumorsP D Buffaz, J P Vuillez, O Chabre, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Journal De Radiologie|September 6, 2005
[Imaging of adrenal ganglioneuroma: a case report]C Dubois, A Jankowski, C Gay-Jeune, et al.
Annales De Cardiologie Et D'Angeiologie|May 17, 2017
[Hyponatremic-hypertensive syndrome successfully treated by endovascular therapy: A case report]G Rigault, B Franko, O Chabre, et al.
Neuro-Chirurgie|June 12, 2002
[Role of perioperative biological tests during the performance and follow-up of corticotroph adenoma exeresis]J G Passagia, E Gay, O Chabre, et al.
The Journal of Biological Chemistry|January 5, 1992
Recombinant Gq alpha. Mutational activation and coupling to receptors and phospholipase CB R Conklin, O Chabre, Y H Wong, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 4, 2007
[Diagnosis and post-operative evolution of patients operated for adrenal adenoma (Conn syndrome). A 12-years retrospective study]C Vesin, O Chabre, J M Mallion, et al.
Annales De Chirurgie|March 31, 2004
[Pelvic muscular metastasis of well differentiated thyroid carcinoma]P C J Chaffanjon, N Sturm, J-P Caravel, et al.
Diabetes & Metabolism|December 3, 2014
Malignant insulinoma may arise during the course of type 1 diabetes mellitus: A case reportS Lablanche, M Chobert-Bakouline, O Risse, et al.
Presse Medicale (Paris, France : 1983)|February 22, 1992
[Cutaneous lesion associated with multiple endocrine neoplasms type 2A (Sipple's syndrome). An early clinical marker]O Chabre, F Labat-Moleur, F Berthod, et al.
Endocrine-Related Cancer|June 13, 2013
Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patientsO Chabre, R Libé, G Assie, et al.
Clinical Nuclear Medicine|June 11, 1999
In-111 pentetreotide scintigraphy to monitor nonsecreting neuroendocrine tumorsP D Buffaz, J P Vuillez, O Chabre, et al.
Pageof 6